European Union Dispute With AstraZeneca Over Vaccine Supply Escalates

The conflict between AstraZeneca and the European Union continued escalating as the bloc strongly accused the pharmaceutical giant of violating a “binding commitment” due to delays of COVID-19 vaccines’ delivery, according to a news release on Wednesday.

According to officials, the conflict started on Monday when AstraZeneca told the EU officials that it would only able to provide “considerably fewer” doses of the COVID-19 vaccines in the coming weeks due to production problems.

However, the bloc has already made an order of 4 million doses of the COVID-19 vaccine.

“Pharmaceutical companies and vaccine developers have moral, societal and contractual responsibilities which they need to uphold,” EU Health Commissioner Stella Kyriakides said in a press briefing on Wednesday. “The view that the company is not obliged to deliver [vaccines] … is neither correct nor acceptable.”

“Not being able to ensure manufacturing capacity is against the letter and the spirit of our agreement,” she added.

According to Kyriakides, the block is going to cooperate with the pharmaceutical giant in order to find solutions to “find solutions and deliver vaccines rapidly for all citizens of each member state.

© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.